-
GSK – Our story
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
Follow GSK on Instagram: https://www.instagram.com/gsk/
published: 12 Sep 2019
-
Is GlaxoSmithKline a Top Pharma Stock? | $GSK Stock Analysis
GlaxoSmithKline albeit a UK stock is still one of those pharma stocks that if you invest in these type of stocks are one that you are likely following.
We have covered a lot of pharma stocks in the time of this channel, from Pfizer to Moderna we have looked at a lot of them. Not all though have jumped out to us as being a strong investment because of their pipeline.
We looked at Bristol Myer Squibb and their pipeline was great in terms of the pharmaceuticals they have in phase 3 and even in the other phases so they are strong there. Just like BMY, GlaxoSmithKline has a strong pipeline as well in what they are looking at bringing out to combat some common diseases that are out there.
Filmed: March 23, 2021
--------------------
We're Giving Away a Tesla!: https://youtu.be/meLCiebxeoQ
🚨🚨🚨...
published: 03 Apr 2021
-
GlaxoSmithKline ($GSK) - Quick Stock Analysis
GlaxoSmithKline is a leader in the pharmaceutical industry but just like AbbVie, you should know what their pipeline is in terms of their products that they offer.
GSK gets the 8 Pillars Stock Analysis that we use to examine the fundamentals on a stock to see how the company looks in the market and to see if its a stock to buy or a stock to watch.
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vac...
published: 04 Jan 2021
-
Is GlaxoSmithKline (GSK) Stock a buy?
In this video we will analyze GlaxoSmithKline (GSK) and compare them with some of the worlds largest pharmaceutical firms, to determine whether GSK stock is currently a buy.
GSK's share price has declined by 25% over the past year. Is it currently undervalued? If so by how much? This is what we will aim to determine in this video.
If you enjoy this video please subscribe to the channel and check out our website - https://www.investment-store.com
published: 07 Feb 2021
-
Is it time to buy GlaxoSmithKline PLC?
What kind of company is GlaxoSmithKline PLC.?
GlaxoSmithKline plc engages in the development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom and internationally.
❗ If you are interested in potentially *living off dividend income and becoming financially independent* then you may be interested in subscribing. ❗
You are very welcome to join me!
🌳Wondering what The Dividend Experiment is all about? Check out the channel trailer to find out whether it's for you...
https://www.youtube.com/watch?v=_W984zkvoL8&list;=PLJjfSo5H-hdBR8hKZ0_J-7b6AvnmLhpHU
🤑Do you want to get a free stock share worth up to £100?🤑
-Get the Trading 212 App:
www.trading212.com/invite/4FWnQwc and we both get ...
published: 20 Oct 2020
-
COVID-19: GlaxoSmithKline, CureVac to develop vaccine against coronavirus variants
Britain's GlaxoSmithKline and Germany's CureVac are teaming up to produce an inoculation that will offer protection against multiple variants of COVID-19. Dr Bharat Pankhania, Senior Clinical Lecturer from the College of Medicine and Health at the University of Exeter, spoke about how the collaboration would improve on existing vaccines.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
published: 03 Feb 2021
-
CureVac Will Make the Next-Gen Covid Shot
Feb.03 -- CureVac has joined forces with GlaxoSmithKline Plc to create a next-generation Covid mRNA shot that could help protect against multiple variants of the pathogen, and it’s extended a partnership with Bayer AG to allow the German pharma giant to produce CureVac’s vaccine. CureVac CEO Franz-Werner Haas spoke on "Bloomberg Markets."
published: 03 Feb 2021
-
GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC
Jim Cramer chats with GlaxoSmithKline CEO Emma Walmsley from J.P. Morgan Chase’s Healthcare Conference. Walmsley breaks down six drug approvals, other research the British drugmaker is seeking.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about GlaxoSmithKline: https://cnb.cx/2QTEUoL
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. ...
published: 16 Jan 2020
-
GSK - GlaxoSmithKline - Aktienanalyse und Dividendenanalyse
#Aktie #Aktien #GlaxoSmithKline #Dividende #Aktienanalyse #FairerPreis #Analyse #GSK #Dividendenstrategie
In diesem Video leite ich mit meiner Aktienanalyse und Dividenden Analyse den fairen Preis und meinen persönlichen Kaufpreis der Aktie und von GlaxoSmithKline her.
Abonnieren nicht vergessen
►►► Kanalinfo Auf dem Kanal Finanzbrille erhältst du regelmäßig Videos zu allen Themen rund um Finanzen und Investitionen. Mein Ziel ist es, transparente Aktienanalysen und Dividendenanalysen vorzustellen. Mit meiner ganz persönlichen Excel-Datei werte ich die Daten aus den Primärquellen von den Investor Relations der jeweiligen Unternehmensseiten aus. Dabei möchte ich neutral die Unternehmen durchleuchten und die Aktien bewerten. Dazu schaue ich mir nicht nur die Dividenden und die Di...
published: 07 Mar 2021
-
Bad Medicine: The Glaxo Case
Drug company whistle-blower Cheryl Eckard tells Scott Pelley about her experience trying to fix problems at a pharmaceutical factory that made her a key figure in a federal lawsuit and a multimillionaire.
published: 02 Jan 2011
3:57
GSK – Our story
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www...
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
Follow GSK on Instagram: https://www.instagram.com/gsk/
https://wn.com/Gsk_–_Our_Story
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
Follow GSK on Instagram: https://www.instagram.com/gsk/
- published: 12 Sep 2019
- views: 48791
11:24
Is GlaxoSmithKline a Top Pharma Stock? | $GSK Stock Analysis
GlaxoSmithKline albeit a UK stock is still one of those pharma stocks that if you invest in these type of stocks are one that you are likely following.
We have...
GlaxoSmithKline albeit a UK stock is still one of those pharma stocks that if you invest in these type of stocks are one that you are likely following.
We have covered a lot of pharma stocks in the time of this channel, from Pfizer to Moderna we have looked at a lot of them. Not all though have jumped out to us as being a strong investment because of their pipeline.
We looked at Bristol Myer Squibb and their pipeline was great in terms of the pharmaceuticals they have in phase 3 and even in the other phases so they are strong there. Just like BMY, GlaxoSmithKline has a strong pipeline as well in what they are looking at bringing out to combat some common diseases that are out there.
Filmed: March 23, 2021
--------------------
We're Giving Away a Tesla!: https://youtu.be/meLCiebxeoQ
🚨🚨🚨 Learn More Here: https://www.everythingmoneytesla.com/ 🚨🚨🚨
⚠️⚠️⚠️No purchase necessary. Void where prohibited. Entrants must be 18 years or older, who reside in the United States, other than New York or Florida. Odds of winning depend on number of entries. Contest begins January 1, 2021 and ends December 31, 2021. Read the Official Rules at https://www.everythingmoneytesla.com/contest-official-rules. Sponsor: Everything Money, LLC, 4816 Brecksville Road, Richfield OH 44286. NEITHER TESLA NOR PATREON HAS SPONSORED OR APPROVED THIS CONTEST.⚠️⚠️⚠️
--------------------
Join our Patreon! - https://www.patreon.com/everythingmoney
--------------------
**WANT BOOKS WE RECOMMEND FOR INVESTING**
The Intelligent Investor: https://amzn.to/3th0qF2
One Up On Wall Street: https://amzn.to/3cBdcs3
Beating The Street: https://amzn.to/36yxMW8
The Little Book That Beats the Market: https://amzn.to/3qfam04
The Complete TurtleTrader: https://amzn.to/3jH2QZc
--------------------
SUBSCRIBE: https://www.youtube.com/channel/UChBV...
Video editing by Rohan and Sharvari (The Tweaky Tales)
⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️
Our channel disclaimer can be found here: https://bit.ly/3n0NxuD
https://wn.com/Is_Glaxosmithkline_A_Top_Pharma_Stock_|_Gsk_Stock_Analysis
GlaxoSmithKline albeit a UK stock is still one of those pharma stocks that if you invest in these type of stocks are one that you are likely following.
We have covered a lot of pharma stocks in the time of this channel, from Pfizer to Moderna we have looked at a lot of them. Not all though have jumped out to us as being a strong investment because of their pipeline.
We looked at Bristol Myer Squibb and their pipeline was great in terms of the pharmaceuticals they have in phase 3 and even in the other phases so they are strong there. Just like BMY, GlaxoSmithKline has a strong pipeline as well in what they are looking at bringing out to combat some common diseases that are out there.
Filmed: March 23, 2021
--------------------
We're Giving Away a Tesla!: https://youtu.be/meLCiebxeoQ
🚨🚨🚨 Learn More Here: https://www.everythingmoneytesla.com/ 🚨🚨🚨
⚠️⚠️⚠️No purchase necessary. Void where prohibited. Entrants must be 18 years or older, who reside in the United States, other than New York or Florida. Odds of winning depend on number of entries. Contest begins January 1, 2021 and ends December 31, 2021. Read the Official Rules at https://www.everythingmoneytesla.com/contest-official-rules. Sponsor: Everything Money, LLC, 4816 Brecksville Road, Richfield OH 44286. NEITHER TESLA NOR PATREON HAS SPONSORED OR APPROVED THIS CONTEST.⚠️⚠️⚠️
--------------------
Join our Patreon! - https://www.patreon.com/everythingmoney
--------------------
**WANT BOOKS WE RECOMMEND FOR INVESTING**
The Intelligent Investor: https://amzn.to/3th0qF2
One Up On Wall Street: https://amzn.to/3cBdcs3
Beating The Street: https://amzn.to/36yxMW8
The Little Book That Beats the Market: https://amzn.to/3qfam04
The Complete TurtleTrader: https://amzn.to/3jH2QZc
--------------------
SUBSCRIBE: https://www.youtube.com/channel/UChBV...
Video editing by Rohan and Sharvari (The Tweaky Tales)
⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️
Our channel disclaimer can be found here: https://bit.ly/3n0NxuD
- published: 03 Apr 2021
- views: 6552
6:46
GlaxoSmithKline ($GSK) - Quick Stock Analysis
GlaxoSmithKline is a leader in the pharmaceutical industry but just like AbbVie, you should know what their pipeline is in terms of their products that they off...
GlaxoSmithKline is a leader in the pharmaceutical industry but just like AbbVie, you should know what their pipeline is in terms of their products that they offer.
GSK gets the 8 Pillars Stock Analysis that we use to examine the fundamentals on a stock to see how the company looks in the market and to see if its a stock to buy or a stock to watch.
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastrointestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
--------------------
Join our Patreon! - https://www.patreon.com/everythingmoney
Check out Charles Schwab and Create Your account today! : http://www.schwab.com/public/schwab/nn/refer-prospect.html?refrid=%7BREFID%7D
--------------------
**WANT BOOKS WE RECOMMEND FOR INVESTING**
The Intelligent Investor: https://amzn.to/3athjmX
One Up On Wall Street: https://amzn.to/2XYJeGf
Beating The Street: https://amzn.to/3ixVXre
--------------------
SUBSCRIBE: https://www.youtube.com/channel/UChBV...
Video editing by Rohan and Sharvari (The Tweaky Tales)
⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️
Our channel disclaimer can be found here: https://bit.ly/3n0NxuD
https://wn.com/Glaxosmithkline_(_Gsk)_Quick_Stock_Analysis
GlaxoSmithKline is a leader in the pharmaceutical industry but just like AbbVie, you should know what their pipeline is in terms of their products that they offer.
GSK gets the 8 Pillars Stock Analysis that we use to examine the fundamentals on a stock to see how the company looks in the market and to see if its a stock to buy or a stock to watch.
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastrointestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
--------------------
Join our Patreon! - https://www.patreon.com/everythingmoney
Check out Charles Schwab and Create Your account today! : http://www.schwab.com/public/schwab/nn/refer-prospect.html?refrid=%7BREFID%7D
--------------------
**WANT BOOKS WE RECOMMEND FOR INVESTING**
The Intelligent Investor: https://amzn.to/3athjmX
One Up On Wall Street: https://amzn.to/2XYJeGf
Beating The Street: https://amzn.to/3ixVXre
--------------------
SUBSCRIBE: https://www.youtube.com/channel/UChBV...
Video editing by Rohan and Sharvari (The Tweaky Tales)
⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️
Our channel disclaimer can be found here: https://bit.ly/3n0NxuD
- published: 04 Jan 2021
- views: 4604
13:05
Is GlaxoSmithKline (GSK) Stock a buy?
In this video we will analyze GlaxoSmithKline (GSK) and compare them with some of the worlds largest pharmaceutical firms, to determine whether GSK stock is cur...
In this video we will analyze GlaxoSmithKline (GSK) and compare them with some of the worlds largest pharmaceutical firms, to determine whether GSK stock is currently a buy.
GSK's share price has declined by 25% over the past year. Is it currently undervalued? If so by how much? This is what we will aim to determine in this video.
If you enjoy this video please subscribe to the channel and check out our website - https://www.investment-store.com
https://wn.com/Is_Glaxosmithkline_(Gsk)_Stock_A_Buy
In this video we will analyze GlaxoSmithKline (GSK) and compare them with some of the worlds largest pharmaceutical firms, to determine whether GSK stock is currently a buy.
GSK's share price has declined by 25% over the past year. Is it currently undervalued? If so by how much? This is what we will aim to determine in this video.
If you enjoy this video please subscribe to the channel and check out our website - https://www.investment-store.com
- published: 07 Feb 2021
- views: 3494
11:16
Is it time to buy GlaxoSmithKline PLC?
What kind of company is GlaxoSmithKline PLC.?
GlaxoSmithKline plc engages in the development, manufacture, and marketing of pharmaceutical products, vaccines, ...
What kind of company is GlaxoSmithKline PLC.?
GlaxoSmithKline plc engages in the development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom and internationally.
❗ If you are interested in potentially *living off dividend income and becoming financially independent* then you may be interested in subscribing. ❗
You are very welcome to join me!
🌳Wondering what The Dividend Experiment is all about? Check out the channel trailer to find out whether it's for you...
https://www.youtube.com/watch?v=_W984zkvoL8&list;=PLJjfSo5H-hdBR8hKZ0_J-7b6AvnmLhpHU
🤑Do you want to get a free stock share worth up to £100?🤑
-Get the Trading 212 App:
www.trading212.com/invite/4FWnQwc and we both get a free share!
-Open an Invest account
-Go to the “Use promo code” menu and enter the promo code. This code gets changed regularly so check here to find the most recent code:
https://www.dividendexperiment.com/special-offers
You can also get a free Share via Freetrade:
https://freetrade.io/dividend-experiment
📚Join The Dividend Academy:
https://the-dividend-academy.teachable.com/p/get-started-investing-today
SOCIALS:
📖 https://www.facebook.com/TheDividendExperiment
📷 https://www.instagram.com/thedividendexperiment/
#dividends #Dividendinvestor #retireearly
https://wn.com/Is_It_Time_To_Buy_Glaxosmithkline_Plc
What kind of company is GlaxoSmithKline PLC.?
GlaxoSmithKline plc engages in the development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom and internationally.
❗ If you are interested in potentially *living off dividend income and becoming financially independent* then you may be interested in subscribing. ❗
You are very welcome to join me!
🌳Wondering what The Dividend Experiment is all about? Check out the channel trailer to find out whether it's for you...
https://www.youtube.com/watch?v=_W984zkvoL8&list;=PLJjfSo5H-hdBR8hKZ0_J-7b6AvnmLhpHU
🤑Do you want to get a free stock share worth up to £100?🤑
-Get the Trading 212 App:
www.trading212.com/invite/4FWnQwc and we both get a free share!
-Open an Invest account
-Go to the “Use promo code” menu and enter the promo code. This code gets changed regularly so check here to find the most recent code:
https://www.dividendexperiment.com/special-offers
You can also get a free Share via Freetrade:
https://freetrade.io/dividend-experiment
📚Join The Dividend Academy:
https://the-dividend-academy.teachable.com/p/get-started-investing-today
SOCIALS:
📖 https://www.facebook.com/TheDividendExperiment
📷 https://www.instagram.com/thedividendexperiment/
#dividends #Dividendinvestor #retireearly
- published: 20 Oct 2020
- views: 5207
3:38
COVID-19: GlaxoSmithKline, CureVac to develop vaccine against coronavirus variants
Britain's GlaxoSmithKline and Germany's CureVac are teaming up to produce an inoculation that will offer protection against multiple variants of COVID-19. Dr Bh...
Britain's GlaxoSmithKline and Germany's CureVac are teaming up to produce an inoculation that will offer protection against multiple variants of COVID-19. Dr Bharat Pankhania, Senior Clinical Lecturer from the College of Medicine and Health at the University of Exeter, spoke about how the collaboration would improve on existing vaccines.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
https://wn.com/Covid_19_Glaxosmithkline,_Curevac_To_Develop_Vaccine_Against_Coronavirus_Variants
Britain's GlaxoSmithKline and Germany's CureVac are teaming up to produce an inoculation that will offer protection against multiple variants of COVID-19. Dr Bharat Pankhania, Senior Clinical Lecturer from the College of Medicine and Health at the University of Exeter, spoke about how the collaboration would improve on existing vaccines.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
- published: 03 Feb 2021
- views: 3504
8:28
CureVac Will Make the Next-Gen Covid Shot
Feb.03 -- CureVac has joined forces with GlaxoSmithKline Plc to create a next-generation Covid mRNA shot that could help protect against multiple variants of th...
Feb.03 -- CureVac has joined forces with GlaxoSmithKline Plc to create a next-generation Covid mRNA shot that could help protect against multiple variants of the pathogen, and it’s extended a partnership with Bayer AG to allow the German pharma giant to produce CureVac’s vaccine. CureVac CEO Franz-Werner Haas spoke on "Bloomberg Markets."
https://wn.com/Curevac_Will_Make_The_Next_Gen_Covid_Shot
Feb.03 -- CureVac has joined forces with GlaxoSmithKline Plc to create a next-generation Covid mRNA shot that could help protect against multiple variants of the pathogen, and it’s extended a partnership with Bayer AG to allow the German pharma giant to produce CureVac’s vaccine. CureVac CEO Franz-Werner Haas spoke on "Bloomberg Markets."
- published: 03 Feb 2021
- views: 3257
9:47
GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC
Jim Cramer chats with GlaxoSmithKline CEO Emma Walmsley from J.P. Morgan Chase’s Healthcare Conference. Walmsley breaks down six drug approvals, other research ...
Jim Cramer chats with GlaxoSmithKline CEO Emma Walmsley from J.P. Morgan Chase’s Healthcare Conference. Walmsley breaks down six drug approvals, other research the British drugmaker is seeking.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about GlaxoSmithKline: https://cnb.cx/2QTEUoL
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC
https://wn.com/Glaxosmithkline_Ceo_Pursuing_Drug_Approvals_|_Mad_Money_|_Cnbc
Jim Cramer chats with GlaxoSmithKline CEO Emma Walmsley from J.P. Morgan Chase’s Healthcare Conference. Walmsley breaks down six drug approvals, other research the British drugmaker is seeking.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about GlaxoSmithKline: https://cnb.cx/2QTEUoL
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC
- published: 16 Jan 2020
- views: 1773
16:28
GSK - GlaxoSmithKline - Aktienanalyse und Dividendenanalyse
#Aktie #Aktien #GlaxoSmithKline #Dividende #Aktienanalyse #FairerPreis #Analyse #GSK #Dividendenstrategie
In diesem Video leite ich mit meiner Aktien...
#Aktie #Aktien #GlaxoSmithKline #Dividende #Aktienanalyse #FairerPreis #Analyse #GSK #Dividendenstrategie
In diesem Video leite ich mit meiner Aktienanalyse und Dividenden Analyse den fairen Preis und meinen persönlichen Kaufpreis der Aktie und von GlaxoSmithKline her.
Abonnieren nicht vergessen
►►► Kanalinfo Auf dem Kanal Finanzbrille erhältst du regelmäßig Videos zu allen Themen rund um Finanzen und Investitionen. Mein Ziel ist es, transparente Aktienanalysen und Dividendenanalysen vorzustellen. Mit meiner ganz persönlichen Excel-Datei werte ich die Daten aus den Primärquellen von den Investor Relations der jeweiligen Unternehmensseiten aus. Dabei möchte ich neutral die Unternehmen durchleuchten und die Aktien bewerten. Dazu schaue ich mir nicht nur die Dividenden und die Dividendenrenditen an, sondern schaue auch darauf wie und in welchen Ländern das Unternehmen aufgestellt ist. Des Weiteren werte ich die Umsatz und Margenentwicklung aus. Abschließend werte ich mit Blick auf die Unternehmensstrategie und einer Sicherheitsmarge den fairen Wert der Aktie bzw. meinen ganz individuellen Kaufpreis der Aktie aus.
►►► Finanzbücher für Dividendeninvestoren:
Cool bleiben und Dividenden kassieren
Bargeld statt Buchgewinn
Geldanlage in Reits: https
►►► Finanzbücher die mein finanzielles Mindset geformt haben:
Rich Dad Poor Dad
Die Prinzipien des Erfolgs
Die Essays von Warren Buffett
Cashflow Quadrant
Money
Think and Grow Rich
►►► Mein Equipment:
Videobearbeitung - Movavi Video Editor Plus
Mikrofon – Rode NT USB
►►►Rechtlicher Hinweis: Der Inhalt dieses Videos und Kanals dient ausschließlich der allgemeinen Information über die Produkte und Dienstleistungen und Anlagestrategien die ich ganz persönlich nutze. Diese Informationen können und sollen eine individuelle Beratung durch hierfür qualifizierte Personen nicht ersetzen. Die Informationen in Bezug auf meine ganz persönliche Anlagestrategie stellen keine Anlageberatung dar. Dieses Video stellt keine Aufforderung zum Kauf oder Verkauf eines Finanzprodukts dar.
https://wn.com/Gsk_Glaxosmithkline_Aktienanalyse_Und_Dividendenanalyse
#Aktie #Aktien #GlaxoSmithKline #Dividende #Aktienanalyse #FairerPreis #Analyse #GSK #Dividendenstrategie
In diesem Video leite ich mit meiner Aktienanalyse und Dividenden Analyse den fairen Preis und meinen persönlichen Kaufpreis der Aktie und von GlaxoSmithKline her.
Abonnieren nicht vergessen
►►► Kanalinfo Auf dem Kanal Finanzbrille erhältst du regelmäßig Videos zu allen Themen rund um Finanzen und Investitionen. Mein Ziel ist es, transparente Aktienanalysen und Dividendenanalysen vorzustellen. Mit meiner ganz persönlichen Excel-Datei werte ich die Daten aus den Primärquellen von den Investor Relations der jeweiligen Unternehmensseiten aus. Dabei möchte ich neutral die Unternehmen durchleuchten und die Aktien bewerten. Dazu schaue ich mir nicht nur die Dividenden und die Dividendenrenditen an, sondern schaue auch darauf wie und in welchen Ländern das Unternehmen aufgestellt ist. Des Weiteren werte ich die Umsatz und Margenentwicklung aus. Abschließend werte ich mit Blick auf die Unternehmensstrategie und einer Sicherheitsmarge den fairen Wert der Aktie bzw. meinen ganz individuellen Kaufpreis der Aktie aus.
►►► Finanzbücher für Dividendeninvestoren:
Cool bleiben und Dividenden kassieren
Bargeld statt Buchgewinn
Geldanlage in Reits: https
►►► Finanzbücher die mein finanzielles Mindset geformt haben:
Rich Dad Poor Dad
Die Prinzipien des Erfolgs
Die Essays von Warren Buffett
Cashflow Quadrant
Money
Think and Grow Rich
►►► Mein Equipment:
Videobearbeitung - Movavi Video Editor Plus
Mikrofon – Rode NT USB
►►►Rechtlicher Hinweis: Der Inhalt dieses Videos und Kanals dient ausschließlich der allgemeinen Information über die Produkte und Dienstleistungen und Anlagestrategien die ich ganz persönlich nutze. Diese Informationen können und sollen eine individuelle Beratung durch hierfür qualifizierte Personen nicht ersetzen. Die Informationen in Bezug auf meine ganz persönliche Anlagestrategie stellen keine Anlageberatung dar. Dieses Video stellt keine Aufforderung zum Kauf oder Verkauf eines Finanzprodukts dar.
- published: 07 Mar 2021
- views: 2346
13:16
Bad Medicine: The Glaxo Case
Drug company whistle-blower Cheryl Eckard tells Scott Pelley about her experience trying to fix problems at a pharmaceutical factory that made her a key figure ...
Drug company whistle-blower Cheryl Eckard tells Scott Pelley about her experience trying to fix problems at a pharmaceutical factory that made her a key figure in a federal lawsuit and a multimillionaire.
https://wn.com/Bad_Medicine_The_Glaxo_Case
Drug company whistle-blower Cheryl Eckard tells Scott Pelley about her experience trying to fix problems at a pharmaceutical factory that made her a key figure in a federal lawsuit and a multimillionaire.
- published: 02 Jan 2011
- views: 67098